Antimicrobial Therapy

Equine Infectious Diseases

Volumn , Issue , 2007, Pages 578-591

  Papich, Mark G ^a   Davis, Jennifer L ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60049085169     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2406-4.50076-4     Document Type: Chapter

References (158)

1. Smith MA, Ross MW Postoperative infection with Actinobacillus spp in horses: 10 cases (1995-2000). J Am Vet Med Assoc 2002, 221(9):1306-1310.
2. Sternberg S, Greko C, Olsson-Liljequist B Antimicrobial susceptibility of equine isolates of Actinobacillus spp. and identification of beta-lactamases in some strains. Microb Drug Resist 1999, 5(4):289-293.
3. Sequin JC, Walker RD, Caron JP, et al. Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmission. J Clin Microbiol 1999, 37:1459-1463.
4. News Methicillin-resistant Staphylococcus aureus: an emerging problem in horses?. J Am Vet Med Assoc 2003, 223(10).
5. Weese JS, Rousseau J, Traub-Dargatz, et al. Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. J Am Vet Med Assoc 2005, 226:580-583.
6. Trostle SS, Peavey CL, King DS, Hartmann FA Treatment of methicillin-resistant Staphylococcus epidermidis infection following repair of an ulnar fracture and humeroradial joint luxation in a horse. J Am Vet Med Assoc 2001, 218(4):554-559.
7. Orsini JA, Ramberg CF, Benson CE, et al. Vancomycin kinetics in plasma and synovial fluid following intravenous administration in horses. J Vet Pharmacol Ther 1992, 15(4):351-363.
8. Sweeney CR, Holcombe SJ, Barningham SC, Beech J Aerobic and anaerobic bacterial isolates from horses with pneumonia or pleuropneumonia and antimicrobial susceptibility patterns of the aerobes. J Am Vet Med Assoc 1991, 198:839-842.
9. Jang SS, Breher JE, Dabaco LA, Hirsh DC Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents. J Am Vet Med Assoc 1997, 210:1610-1614.
10. Hirsh DC, Indiveri MC, Jang SS, Biberstein EL Changes in prevalence and susceptibility of obligate anaerobes in clinical veterinary practice. J Am Vet Med Assoc 1985, 186:1086-1089.
11. Oluoch AO, Kim CH, Weisiger RM, et al. Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998). J Am Vet Med Assoc 2001, 218:381-384.
12. Walker AL, Jang SS, Hirsh DC Bacteria associated with pyothorax of dogs and cats: 98 cases (1989-1998). J Am Vet Med Assoc 2000, 216:359-363.
13. Orsini JA, Benson CE, Spencer PA, Van Miller E Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses. Am J Vet Res 1989, 50:923-925.
14. Dowling PM, Wilson RC, Tyler JW, Duran SH Pharmacokinetics of ciprofloxacin in ponies. J Vet Pharmacol Ther 1995, 18:7-12.
15. Latimer FG, Colitz CM, Campbell NB, Papich MG Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses. Am J Vet Res 2001, 62(10):1606-1611.
16. Clinical and Laboratory Standards Institute (CLSI): Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved guideline M23-A2, Second Edition, Wayne, Pa, 2001.
17. Clinical and Laboratory Standards Institute: Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved guideline M37-A2, Second Edition, Wayne, Pa, 2002.
18. Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved standard M31-A2, Second Edition, Wayne, Pa, 2002.
19. Hyatt JM, McKinnon PS, Zimmer GS, Schentag JJ The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Clin Pharmacokinet 1995, 28:143-160.
20. Nicolau DP, Quintiliani R, Nightingale CH Antibiotic kinetics and dynamics for the clinician. Med Clin North Am 1995, 79:477-495.
21. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 1997, 39:677.
22. Maglio D, Nightingale CH, Nicolau DP Extended interval aminoglycoside dosing: from concept to clinic. Int J Antimicrob Agents 2002, 19:341-348.
23. Tudor RA, Papich MG, Redding WR Gentamicin disposition and dosage determination of once daily administration of gentamicin sulfate in horses after abdominal surgery. J Am Vet Med Assoc 1999, 215(4):503-506.
24. Dudley MN Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones. Am J Med 1991, 91(suppl 6A):45S-50S.
25. Wright DH, Brown GH, Peterson ML, Rotschafer JC Application of fluoroquinolone pharmacodynamics. J Antimicrob Chemother 2000, 46:669-683.
26. Papich MG, Riviere JE Fluoroquinolones. Veterinary pharmacology and therapeutics 2001, Iowa State University Press, Ames. ed 8. H.R. Adams (Ed.).
27. Lode H, Borner K, Koeppe P Pharmacodynamics of fluoroquinolones. Clin Infect Dis 1998, 27:33-39.
28. Walker RD Fluoroquinolones. Antimicrobial therapy in veterinary medicine 2000, Iowa State University Press, Ames. ed 3. J.F. Prescott, J.D. Baggot, R.D. Walker (Eds.).
29. Papich MG, Van Camp SD, Cole J, Whitacre MD Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after IV administration of enrofloxacin to mares. J Vet Pharmacol Ther 2002, 25:343-350.
30. Giguére S, Sweeney RW, Bélanger M Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. Am J Vet Res 1996, 57:1025-1030.
31. Langston VC, Sedrish S, Boothe DM Disposition of single-dose oral enrofloxacin in the horse. J Vet Pharmacol Ther 1996, 19:316-319.
32. Pyörälä S, Panu S, Kaartinen L Single dose pharmacokinetics of ciprofloxacin in horses. Proc EAVPT 1994, 45-46.
33. Turnidge JD The pharmacodynamics of β-lactams. Clin Infect Dis 1998, 27:10-22.
34. Davis JL, Gardner SY, Jones SL, et al. Pharmacokinetics of azithromycin in foals after iv and oral dose and disposition into phagocytes. J Vet Pharmacol Ther 2002, 25:99-104.
35. Jacks S, Giguère S, Gronwall RR, et al. Disposition of oral clarithromycin in foals. J Vet Pharmacol Ther 2002, 25(5):359-362.
36. Bertone AL, McIlwraith CW, Jones RL, et al. Comparison of various treatments for experimentally induced equine infectious arthritis. Am J Vet Res 1987, 48:519-529.
37. Nix DE, Goodwin SD, Peloquin CA, et al. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrob Agents Chemother 1991, 35:1953-1959.
38. Ryan DM Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993, 31(suppl D):1-16.
39. Anderson BH, Firth EC, Whittem T The disposition of gentamicin in equine plasma, synovial fluid and lymph. J Vet Pharmacol Ther 1995, 18:124-131.
40. Van Camp SD, Papich MG, Whitacre MD Administration of ticarcillin in combination with clavulanic acid intravenously and intrauterinely to clinically normal estrous mares. J Vet Pharmacol Ther 2000, 23:373-378.
41. Bowman KF, Dix LP, Riond JL, Riviere JE Prediction of pharmacokinetic profiles of ampicillin sodium, gentamicin sulfate, and combination ampicillin sodium-gentamicin sulfate in serum and synovia of healthy horses. Am J Vet Res 1986, 47:1590-1595.
42. Ensink JM, Klein WR, Mevius DJ, et al. Bioavailability of oral penicillins in the horse: a comparison of pivampicillin and amoxicillin. J Vet Pharmacol Ther 1992, 15:221-230.
43. Firth EC, Klein WR, Nouws JFM, Wensing TH Effect of induced synovial inflammation on pharmacokinetics and synovial concentrations of sodium ampicillin and kanamycin sulfate after systemic administration in ponies. J Vet Pharmacol Ther 1988, 11:56-62.
44. Short CR, Beadle RE, Aranas T, et al. Distribution of cephapirin into a tissue chamber implanted subcutaneously in horses. J Vet Pharmacol Ther 1987, 10:241-247.
45. Baldwin DR, Honeybourne D, Wise R Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 1992, 36:1171-1175.
46. Brown MP, Embertson RM, Gronwall RR, et al. Amikacin sulfate in mares: pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration. Am J Vet Res 1984, 45(8):1610-1613.
47. Zertuche JML, Hillidge CJ Therapeutic considerations for Rhodococcus equi pneumonia in foals. Compend Contin Educ Pract Vet 1987, 9:965-971.
48. Pascual A Uptake and intracellular activity of antimicrobial agents in phagocytic cells. Rev Med Microbiol 1995, 6:228-235.
49. Davis JL, Salmon JH, Papich MG Pharmacokinetics and tissue distribution of doxycycline in the horse following administration of single and multiple oral doses. Am J Vet Res 2006, 67(2):310-316.
50. Giguère S, Jacks S, Roberts GD, et al. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J Vet Intern Med 2004, 18(4):568-573.
51. Jacks SS, Giguère S, Nguyen A In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. Antimicrob Agents Chemother 2003, 47(5):1742-1745.
52. Habash M, Reid G Microbial biofilms: their development and significance for medical device-related infections. J Clin Pharmacol 1999, 39:887-898.
53. Smith AW Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?. Adv Drug Deliv Rev 2005, 57:1539-1550.
54. Van Duijkeren E, Vulto AG, van Miert AS Trimethoprim-sulfonamide combinations in the horse: a review. J Vet Pharmacol Ther 1994, 17:64-73.
55. Ensink JM, Smit JA, Van Duijkeren E Clinical efficacy of trimethoprim/sulfadiazine and procaine penicillin G in a Streptococcus equi subsp. zooepidemicus infection model in ponies. J Vet Pharmacol Ther 2003, 26:247-252.
56. Ensink JM, Bosch G, Van Duijkeren E Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp. zooepidemicus infection model in ponies. J Vet Pharmacol Ther 2005, 28:45-49.
57. Uboh CE, Soma LR, Luo Y, et al. Pharmacokinetics of penicillin G procaine versus penicillin G potassium and procaine hydrochloride in horses. Am J Vet Res 2000, 61:811-815.
58. Firth EC, Nouws JFM, Driessens F, et al. Effect of the injection site on the pharmacokinetics of procaine penicillin G in horses. Am J Vet Res 1986, 47:2380-2383.
59. Papich MG, Korsrud GO, Boison JO, et al. A study of the disposition of procaine penicillin G in feedlot steers following intramuscular and subcutaneous injection. J Vet Pharmacol Ther 1993, 16:317-327.
60. Baggot JD Bioavailability and bioequivalence of veterinary drug dosage forms, with particular reference to horses: an overview. J Vet Pharmacol Ther 1992, 15(2):160-173.
61. Wilson WD, Spensley MS, Baggot JD, Hietala SK Pharmacokinetics and estimated bioavailability of amoxicillin in mares, after intravenous, intramuscular, and oral administration. Am J Vet Res 1988, 49:1688-1693.
62. Ensink JM, Vulto AG, van Miert AS, et al. Oral bioavailability an in vitro stability of pivampicillin, bacampicillin, talampicillin, and ampicillin in horses. Am J Vet Res 1996, 57:1021-1024.
63. Baggot JD Bioavailability and disposition kinetics of amoxicillin in neonatal foals. Equine Vet J 1988, 20:125-127.
64. Duffee NE, Christensen JM, Craig AM The pharmacokinetics of cefadroxil in the foal. J Vet Pharmacol Ther 1989, 12:322-326.
65. Wilson WD, Baggot JD, Adamson PJW, et al. Cefadroxil in the horse: pharmacokinetics and in vitro antibacterial activity. J Vet Pharmacol Ther 1985, 8:246-253.
66. Davis JL, Salmon JH, Papich MG Pharmacokinetics and tissue distribution ofcephalexin in the horse after oral and intravenous administration. J Vet Pharmacol Ther 2005, 28:425-431.
67. Sarasola P, McKellar QA Ampicillin and its congener prodrugs in the horse. Br Vet J 1994, 150:173-187.
68. Lakritz J, Wilson WD, Marsh AE, Mihalyi JE Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals. Am J Vet Res 2000, 61:1011-1015.
69. Lakritz J, Wilson WD, Marsh AE, Mihalyi JE Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. Am J Vet Res 2000, 61:914-919.
70. Carrillo NA, Giguère S, Gronwall, et al. Disposition of orally administered cefpodoxime proxetil in foals and adult horses and minimum inhibitory concentration of the drug against common bacterial pathogens of horses. Am J Vet Res 2005, 66:30-35.
71. Van Duijkeren E, Kessels BG, Sloet van Oldruitenborgh-Oosterbaan MM, et al. In vitro and in vivo binding of trimethoprim and sulphachlorpyridazine to equine food and digesta and their stability in caecal contents. J Vet Pharmacol Ther 1996, 19(4):281-287.
72. Van Duijkeren E, Vulto AG, Sloet van Oldruitenborgh-Oosterbaan MM, et al. Pharmacokinetics of trimethoprim/sulphachlorpyridazine in horses after oral, nasogastric and intravenous administration. J Vet Pharmacol Ther 1995, 18(1):47-53.
73. Lloyd KCK, Stover SM, Pascoe JR, et al. Plasma and synovial fluid concentrations of gentamicin in horses after intra-articular administration of buffered and unbuffered gentamicin. Am J Vet Res 1988, 49:644-649.
74. Murphey ED, Santschi EM, Papich MG Regional intravenous perfusion of the distal limb of horses with amikacin sulfate. J Vet Pharmacol Ther 1999, 22:68-71.
75. Caprile KA, Short CR Pharmacologic considerations in drug therapy in foals. Vet Clin North Am Equine Pract 1987, 3:123.
76. McFarlane D, Papich MG, Breuhaus B, et al: Pharmacokinetics of amikacin sulfate in sick and healthy foals. In Proceedings of the 5th Conference of the International Veterinary Emergency and Critical Care Society, 1996, San Antonio, Texas (abstract).
77. Bucki EP, Giguère S, Macpherson M, Davis R Pharmacokinetics of once-daily amikacin in healthy foals and therapeutic drug monitoring in hospitalized equine neonates. J Vet Intern Med 2004, 18(5):728-733.
78. Orsini JA, Soma LR, Rourke JE, Park M Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration. J Vet Pharmacol Ther 1985, 8(2):194-201.
79. Rossdale PD, Cash RS, Leadon DP, Jeffcott LB Biochemical constituents of cerebrospinal fluid in premature and full term foals. Equine Vet J 1982, 14(2):134-138.
80. Adamson PJ, Wilson WD, Baggot JD, et al. Influence of age on the disposition kinetics of chloramphenicol in equine neonates. Am J Vet Res 1991, 52(3):426-431.
81. Bermingham EC, Papich MG, Vivrette SL Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. Am J Vet Res 2000, 61(6):706-709.
82. Prescott JF, Staempfli HR, Barker IK, et al. A method for reproducing fatal idiopathic colitis (colitis X) in ponies and isolation of a clostridium as a possible agent. Equine Vet J 1988, 20(6):417-420.
83. Brashier MK, Geor RJ, Ames TR, O'Leary TP Effect of intravenous calcium administration on gentamicin-induced nephrotoxicosis in ponies. Am J Vet Res 1998, 59(8):1055-1062.
84. Riond JL, Riviere JE, Duckett WM, et al. Cardiovascular effects and fatalities associated with intravenous administration of doxycycline to horses and ponies. Equine Vet J 1992, 24(1):41-45.
85. Bowen JM, McMullan WC Influence of induced hypermagnesemia and hypocalcemia on neuromuscular blocking property of oxytetracycline in the horse. Am J Vet Res 1975, 36(7):1025-1028.
86. Yoon JH, Brooks RL, Khan A, et al. The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells. Cell Biol Toxicol 2004, 20(1):41-54.
87. Egerbacher M, Edinger J, Tschulenk W Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am J Vet Res 2001, 62(5):704-708.
88. Bertone AL, Tremaine WH, Macoris DG, et al. Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses. J Am Vet Med Assoc 2000, 217(10):1514-1521.
89. Madison JB, Garber JL, Rice B, et al. Effect of oxytetracycline on metacarpophalangeal and distal interphalangeal joint angles in newborn foals. J Am Vet Med Assoc 1994, 204(2):246-249.
90. Kasper CA, Clayton HM, Wright AK, et al. Effect of high doses of oxytetracycline on metacarpophalangeal joint kinematics in neonatal foals. J Am Vet Med Assoc 1995, 207:71-73.
91. Papich MG, Wright AK, Petrie L, Korsrud GO Pharmacokinetics of oxytetracycline administered intravenously to 4- to 5-day-old foals. J Vet Pharmacol Ther 1995, 18(5):375-378.
92. Aho P, Mannisto PT Effects of two erythromycins, doxycycline and phenoxymethylpenicillin on human leucocyte chemotaxis in vitro. J Antimicrob Chemother 1988, 21(suppl D):29-32.
93. Healy DP, Silverman PA, Neely AN, et al. Effect of antibiotics on polymorphonuclear neutrophil apoptosis. Pharmacotherapy 2002, 22(5):578-585.
94. Back O, Norberg B The effect of a therapeutic doxycycline concentration on polymorphonuclear leukocyte migration in vitro. Scand J Infect Dis 1984, 16(4):369-372.
95. Back O, Norberg B Effect of a single oral dose of doxycycline on polymorphonuclear leukocyte migration in a casein gradient. Eur J Clin Pharmacol 1985, 28(2):193-195.
96. Krakauer T, Buckley M Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents Chemother 2003, 47(11):3630-3633.
97. Hanemaaijer R, Visser H, Koolwijk P, et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res 1998, 12(2):114-118.
98. Solomon A, Rosenblatt M, Li DQ, et al. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci 2000, 41(9):2544-2557.
99. Brooks DE, Ollivier FJ Matrix metalloproteinase inhibition in corneal ulceration. Vet Clin North Am Small Anim Pract 2004, 34(3):611-622.
100. Krakauer T, Pitt L, Hunt RE Detection of interleukin-6 and interleukin-2 in serum of rhesus monkeys exposed to a nonlethal dose of staphylococcal enterotoxin B. Mil Med 1997, 62(9):612-615.
101. Bamias G, Marini M, Moskaluk CA, et al. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J Immunol 2002, 169(9):5308-5314.
102. Koenig JB, Cote N, LaMarre J, et al. Binding of radiolabeled porcine motilin and erythromycin lactobionate to smooth muscle membranes in various segments of the equine gastrointestinal tract. Am J Vet Res 2002, 63(11):1545-1550.
103. Durando MM, MacKay RJ, Linda S, Skelley LA Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Am J Vet Res 1994, 55(7):921-927.
104. Parviainen AK, Barton MH, Norton NN Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Am J Vet Res 2001, 62(1):72-76.
105. Barton MH Update on equine therapeutics: use of polymyxin B for treatment of endotoxemia in horses. Compend Contin Educ Equine Pract 2000, 22(11):1056-1059.
106. Davis JL, Papich MG, Weingarten A The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. J Vet Pharmacol Ther 2006, 29:191-197.
107. Bousquet-Mélou A, Bernard S, Schneider M, Toutain PL Pharmacokinetics of marbofloxacin in horses. Equine Vet J 2002, 34:366-372.
108. Peyrou M, Ducet MY, Vrins A, et al. Population pharmacokinetics of marbofloxacin in horses: preliminary analysis. J Vet Pharmacol Ther 2004, 27:283-288.
109. Carretero M, Rodriguez C, San Andres MI, et al. Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration. Equine Vet J 2002, 34:360-365.
110. Haines GR, Brown MP, Gronwall RR, Merritt KA Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares. Can J Vet Res 2000, 64:171-177.
111. Boeckh C, Buchanan C, Boeckh A, et al. Pharmacokinetics of the bovine formulation of enrofloxacin (Baytril 100) in horses. Vet Ther 2001, 2:129-134.
112. Epstein K, Cohen N, Boothe D, et al. Pharmacokinetics, stability, and retrospective analysis of use of an oral gel formulation of the bovine injectable enrofloxacin in horses. Vet Ther Summer 2004, 5(2):155-167.
113. Gardner SY, Davis JL, Jones SL, et al. Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. J Vet Pharmacol Ther 2004, 27(1):57-60.
114. Jacks S, Giguère S, Gronwall PR, et al. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. Am J Vet Res 2001, 62(12):1870-1875.
115. Girard D, Finegan SM, Dunne MW, Lame ME Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models. J Antimicrob Chemother 2005, 56(2):365-371.
116. Traver DS, Riviere JE Ampicillin in mares: a comparison of intramuscular sodium ampicillin or sodium ampicillin-ampicillin trihydrate injection. Am J Vet Res 1982, 43(3):402-404.
117. Sarasola P, McKellar QA Effect of probenecid on disposition kinetics of ampicillin in horses. Vet Rec 1992, 131:173-175.
118. Sarasola P, McKellar QA Pharmacokinetics and applications of ampicillin sodium as an intravenous infusion in the horse. J Vet Pharmacol Ther 1993, 16:63-69.
119. Durr A Comparison of the pharmacokinetics of penicillin G and ampicillin in the horse. Res Vet Sci 1976, 20:24-29.
120. Sams RA, Ruoff WW Pharmacokinetics and bioavailability of cefazolin in horses. Am J Vet Res 1985, 46(2):348-352.
121. Donecker JM, Sams RA, Ashcraft SM Pharmacokinetics of probenecid and the effect of oral probenecid administration on the pharmacokinetics of cefazolin in mares. Am J Vet Res 1986, 47(1):89-95.
122. Jaglan PS, Roof RD, Yein FS, et al. Concentration of ceftiofur metabolites in the plasma and lungs of horses following intramuscular treatment. J Vet Pharmacol Ther 1994, 17:24-30.
123. Guglick MA, MacAllister CG, Clarke CR, et al. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses. Am J Vet Res 1998, 59(4):458-463.
124. Gardner SY, Papich MG Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs. J Vet Pharmacol Ther 2001, 24(3):187-192.
125. Godber LM, Walker RD, Stein GE, et al. Pharmacokinetics, nephrotoxicosis, and in vitro antibacterial activity associated with single versus multiple (three times) daily gentamicin treatments in horses. Am J Vet Res 1995, 56:613.
126. Martin-Jimenez T, Papich MG, Riviere JE Population pharmacokinetics of gentamicin in horses. Am J Vet Res 1998, 59:1589-1598.
127. Geor RJ, Papich MG Once-daily aminoglycoside dosing regimens. Current therapy in equine medicine 2003, 850-853. Elsevier, St Louis. ed 5. N.E. Robinson (Ed.).
128. Greko C, Bengtsson B, Franklin A, et al. Efficacy of trimethoprim-sulfadoxine against Escherichia coli in a tissue cage model in calves. J Vet Pharmacol Ther 2002, 25:413-423.
129. Van Duijkeren E, Ensink JM, Meijer LA Distribution of orally administered trimethoprim and sulfadiazine into noninfected subcutaneous tissue chambers in adult ponies. J Vet Pharmacol Ther 2002, 25:273-277.
130. Brown MP, Gronwall R, Castro L Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares. Am J Vet Res 1988, 49:918-922.
131. Bertone AL, Jones RL, McIlwraith CW Serum and synovial fluid steady-state concentrations of trimethoprim and sulfadiazine in horses with experimentally induced infectious arthritis. Am J Vet Res 1988, 49:1681-1686.
132. Prades M, Brown MP, Gronwall R, Houston AE Body fluid and endometrial concentrations of ketoconazole in mares after intravenous injection or repeated gavage. Equine Vet J 1989, 21(3):211-214.
133. Taintor J, Crowe C, Hancock S, et al. Treatment of conidiobolomycosis with fluconazole in two pregnant mares. J Vet Intern Med 2004, 18(3):363-364.
134. Davis JL, Salmon JH, Papich MG Pharmacokinetics and tissue distribution of itraconazole after oral and intravenous administration to horses. Am J Vet Res 2005, 66(10):1694-1701.
135. Davis EW, Legendre AM Successful treatment of guttural pouch mycosis with itraconazole and topical enilconazole in a horse. J Vet Intern Med 1994, 8(4):304-305.
136. Foley JP, Legendre AM Treatment of coccidioidomycosis osteomyelitis with itraconazole in a horse: a brief report. J Vet Intern Med 1992, 6(6):333-334.
137. Korenek NL, Legendre AM, Andrews FM, et al. Treatment of mycotic rhinitis with itraconazole in three horses. J Vet Intern Med 1994, 8(3):224-227.
138. Davis JL, Salmon JH, Papich MG The pharmacokinetics of voriconazole in the horse following oral and intravenous administration. Am J Vet Res 2006, 67(6):1070-1075.
139. Madison JB, Reid BV, Raskin RE Amphotericin B treatment of Candida arthritis in two horses. J Am Vet Med Assoc 1995, 206(3):338-341.
140. Reilly LK, Palmer JE Systemic candidiasis in four foals. J Am Vet Med Assoc 1994, 205(3):464-466.
141. Schutte JG, van den Ingh TS Microphthalmia, brachygnathia superior, and palatocheiloschisis in a foal associated with griseofulvin administration to the mare during early pregnancy. Vet Q 1997, 19(2):58-60.
142. Hector RF, Davidson AP, Johnson SM Comparison of susceptibility of fungal isolates to lufenuron and nikkomycin Z alone or in combination with itraconazole. Am J Vet Res 2005, 66(6):1090-1093.
143. Rees WA, Harkins JD, Woods WE, et al. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J 1997, 29(2):104-110.
144. Rees WA, Harkins JD, Lu M, et al. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Am J Vet Res 1999, 60(7):888-894.
145. Friday PA, Scarratt WK, Elvinger F, et al. Ataxia and paresis with equine herpesvirus type 1 infection in a herd of riding school horses. J Vet Intern Med 2000, 14(2):197-201.
146. Murray MJ, del Piero F, Jeffrey SC, et al. Neonatal equine herpesvirus type 1 infection on a Thoroughbred breeding farm. J Vet Intern Med 1998, 12(1):36-41.
147. Wilkins PA Acyclovir in the treatment of EHV-1 myeloencephalopathy. Proc Am Coll Vet Med 2004.
148. Wilkins PA, Papich MG, Sweeney RW Pharmacokinetics of acyclovir in adult horses. J Vet Emerg Crit Care 2005, 15(3):174-178.
149. De la Fuente R, Awan AR, Field HJ The acyclic nucleoside analogue penciclovir is a potent inhibitor of equine herpesvirus type 1 (EHV-1) in tissue culture and in a murine model. Antiviral Res 1992, 18(1):77-89.
150. Moore BR, Krakowka S, Mcvey DS, et al. Inflammatory markers in bronchoalveolar lavage fluid of Standardbred racehorses with inflammatory airway disease: response to interferon-alpha. Equine Vet J 1997, 29(2):142-147.
151. Lindsay DS, Butler JM, Rippey NS, et al. Demonstration of synergistic effects of sulfonamides and dihydrofolate reductase/thymidylate synthase inhibitors against Neospora caninum tachyzoites in cultured cells, and characterization of mutants resistant to pyrimethamine. Am J Vet Res 1996, 57(1):68-72.
152. Piercy RJ, Hinchcliff KW, Reed SM Folate deficiency during treatment with orally administered folic acid, sulphadiazine and pyrimethamine in a horse with suspected equine protozoal myeloencephalitis (EPM). Equine Vet J 2002, 34(3):311-316.
153. Toribio RE, Bain FT, Mrad DR, et al. Congenital defects in newborn foals of mares treated for equine protozoal myeloencephalitis during pregnancy. J Am Vet Med Assoc 1998, 212(5):697-701.
154. Dirikolu L, Lehner F, Nattrass C, et al. Diclazuril in the horse: its identification and detection and preliminary pharmacokinetics. J Vet Pharmacol Ther 1999, 22(6):374-379.
155. Lescun TB, Ward MP, Adams SB Gentamicin concentrations in synovial fluid and joint tissues during intravenous administration or continuous intra-articular infusion of the tarsocrural joint of clinically normal horses. Am J Vet Res 2006, 67(3):409-416.
156. Rubio-Martinez LM, Cruz AM Antimicrobial regional limb perfusion in horses. J Am Vet Med Assoc 2006, 228(5):706-712.
157. Morresey PR, MacKay RJ Endotoxin-neutralizing activity of polymyxin B in blood after IV administration in horses. Am J Vet Res 2006, 67(4):642-647.
158. Belloli C, Crescenzo G, Lai O, et al. Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration. Equine Vet J 2002, 34(6):625-629.